サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1612855

in vitroタンパク質発現の世界市場：産業分析・規模・シェア・成長・動向・予測 (2024-2031年)

In Vitro Protein Expression Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

出版日
ページ情報
英文 210 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
in vitroタンパク質発現の世界市場：産業分析・規模・シェア・成長・動向・予測 (2024-2031年)
出版日: 2024年12月12日
発行: Persistence Market Research
ページ情報: 英文 210 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

主な洞察

  • in vitroタンパク質発現の市場規模 (2024年)：2億3,950万米ドル
  • 市場規模の予測 (2031年)：3億8,590万米ドル
  • 世界の市場成長率 (2024～2031年)：CAGR 7.1%

市場成長促進要因：

世界のin vitroタンパク質発現市場の成長を後押ししている要因には、タンパク質ベースの治療薬に対する需要の高まり、創薬プロセスにおける迅速なタンパク質合成の必要性、個別化医療への注目の高まりなどがあります。分子生物学的技術の進歩と堅牢な発現システムのアベイラビリティが、この成長を促進しています。また、バイオテクノロジー研究に対する政府の資金援助や、学術機関とバイオ医薬品企業との提携も市場拡大に寄与しています。

市場抑制要因：

有望な成長見通しである一方で、in vitroタンパク質発現市場は特定の課題に直面しています。タンパク質発現システムや試薬に関連する高コスト性が、特に中小企業にとって大きな障壁となっています。また、技術的な複雑さと熟練した人材の必要性が市場普及をさらに抑制しています。さらに、治療薬への組換えタンパク質の使用に関する規制上の課題も同市場の成長を制限する可能性があります。

市場機会：

in vitroタンパク質発現市場では、ハイスループットスクリーニング用途での無細胞タンパク質合成の採用の増加が大きな成長機会となっています。費用対効果が高く効率的な発現システムの開発により、市場の魅力が高まることが予想されています。また、合成生物学が重視されるようになり、CRISPR-Cas9などの遺伝子編集技術が進歩することで、技術革新の新たな道が開かれます。抗体開発、ワクチン生産、バイオセンサー設計などの分野におけるタンパク質発現の市場の発展が市場機会をさらに拡大させています。

当レポートでは、世界のin vitroタンパク質発現の市場を調査し、市場の定義と概要、市場促進要因・抑制要因、各種動向、市場機会、課題、市場規模 (金額・一部数量) の推移・予測、各種区分・地域/主要国別の詳細分析、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の分類
  • 市場の定義
  • 製品比較

第3章 市場の視点

  • マクロ経済要因
  • 促進要因
    • 供給サイドの要因
    • 需要サイドの要因
  • 抑制要因
  • 機会分析
  • 動向
  • 地域別の価格分析
  • 主要な洞察

第4章 北米のin vitroタンパク質発現市場の分析・予測

  • 市場規模の推移・予測：国別
    • 米国
    • カナダ
  • 市場規模の推移・予測：製品タイプ別
    • 大腸菌i
    • ウサギ網状赤血球
    • 小麦胚芽
    • 昆虫細胞
    • 哺乳類i
  • 市場規模の推移・予測：用途別
    • 酵素工学
    • タンパク質の標識
    • タンパク質間相互作用
    • タンパク質精製
  • 市場規模の推移・予測：発現システム別
    • 連続フロー発現システム
    • バッチ発現システム
  • 市場規模の推移・予測：エンドユーザー別
    • バイオテクノロジー企業
    • 製薬会社
    • CRO
    • 学術研究機関
  • 市場の魅力分析
  • 促進要因と抑制要因：影響分析
  • 主要参加者の市場プレゼンス (強度マップ)

第5章 ラテンアメリカのin vitroタンパク質発現市場の分析・予測

  • 市場規模の推移・予測：国別
    • ブラジル
    • メキシコ
    • アルゼンチン
    • その他
  • 市場規模の推移・予測：製品タイプ別
  • 市場規模の推移・予測：用途別
  • 市場規模の推移・予測：発現システム別
  • 市場規模の推移・予測：エンドユーザー別
  • 市場の魅力分析
  • 促進要因と抑制要因：影響分析
  • 主要参加者の市場プレゼンス (強度マップ)

第6章 欧州のin vitroタンパク質発現市場の分析・予測

  • 市場規模の推移・予測：国別
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • ポーランド
    • ロシア
    • その他
  • 市場規模の推移・予測：製品タイプ別
  • 市場規模の推移・予測：用途別
  • 市場規模の推移・予測：発現システム別
  • 市場規模の推移・予測：エンドユーザー別
  • 市場の魅力分析
  • 促進要因と抑制要因：影響分析
  • 主要参加者の市場プレゼンス (強度マップ)

第7章 アジア太平洋地域のin vitroタンパク質発現市場の分析・予測

  • 市場規模の推移・予測：国別
    • 中国
    • 日本
    • オーストラリア
    • インド
    • その他
  • 市場規模の推移・予測：製品タイプ別
  • 市場規模の推移・予測：用途別
  • 市場規模の推移・予測：発現システム別
  • 市場規模の推移・予測：エンドユーザー別
  • 市場の魅力分析
  • 促進要因と抑制要因：影響分析
  • 主要参加者の市場プレゼンス (強度マップ)

第8章 中東・アフリカのin vitroタンパク質発現市場の分析・予測

  • 市場規模の推移・予測：国別
    • GCC諸国
    • 南アフリカ
    • その他
  • 市場規模の推移・予測：製品タイプ別
  • 市場規模の推移・予測：用途別
  • 市場規模の推移・予測：発現システム別
  • 市場規模の推移・予測：エンドユーザー別
  • 市場の魅力分析
  • 促進要因と抑制要因：影響分析
  • 主要参加者の市場プレゼンス (強度マップ)

第9章 予測要因：関連性と影響

第10章 競合情勢

  • 市場構造
  • 企業シェア分析
  • 競合ダッシュボード
  • 企業プロファイル（詳細：概要、財務、戦略、最近の動向、SWOT分析）
    • Thermo Fisher Scientific, Inc.
    • Takara Bio Company
    • New England Biolabs
    • Promega Corporation
    • Jena Bioscience GmbH
    • GeneCopoeia, Inc.
    • Biotechrabbit GmbH
    • Cube Biotech GmbH
    • CellFree Sciences Co., Ltd.
    • Bioneer Corporation

第11章 世界のin vitroタンパク質発現市場分析・予測：地域別

第12章 世界のin vitroタンパク質発現市場分析・予測：製品タイプ別

第13章 世界のin vitroタンパク質発現市場分析・予測：用途別

第14章 世界のin vitroタンパク質発現市場分析・予測：発現システム別

第15章 世界のin vitroタンパク質発現市場分析・予測：エンドユーザー別

第16章 世界市場の分析・予測

  • 収益機会
  • 市場規模・前年比成長率
  • バリューチェーン

第17章 調査手法

目次
Product Code: PMRREP21727

Persistence Market Research has recently released a comprehensive report on the global In Vitro Protein Expression Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • In Vitro Protein Expression Market Size (2024E): US$239.5 Mn
  • Projected Market Value (2031F): US$385.9 Mn
  • Global Market Growth Rate (CAGR 2024 to 2031): 7.1%

In Vitro Protein Expression Market - Report Scope:

The global in vitro protein expression market encompasses a wide range of expression systems, including cell-free protein expression, prokaryotic expression systems, and eukaryotic expression systems. Market growth is primarily fueled by the increasing demand for recombinant protein production, advancements in synthetic biology, and the rising adoption of cell-free protein synthesis technologies. The market's expansion is further supported by growing research activities in proteomics and the pharmaceutical sector.

Market Growth Drivers:

Several factors are driving the growth of the global in vitro protein expression market. These include the escalating demand for protein-based therapeutics, the need for rapid protein synthesis in drug discovery processes, and the increasing focus on personalized medicine. Advancements in molecular biology techniques and the availability of robust expression systems are facilitating this growth. Additionally, government funding for biotechnological research and partnerships between academic institutions and biopharma companies contribute to market expansion.

Market Restraints:

Despite the promising growth prospects, the in vitro protein expression market faces certain challenges. High costs associated with protein expression systems and reagents act as significant barriers, particularly for small and medium-sized enterprises. Technical complexities and the need for skilled personnel further restrict market penetration. Moreover, the regulatory challenges related to the use of recombinant proteins in therapeutics may limit the market's growth potential.

Market Opportunities:

The in vitro protein expression market presents significant growth opportunities driven by the rising adoption of cell-free protein synthesis for high-throughput screening applications. The development of cost-effective and efficient expression systems is expected to attract more players to the market. Additionally, the growing emphasis on synthetic biology and advancements in gene-editing technologies like CRISPR-Cas9 open new avenues for innovation. Expanding applications of protein expression in areas such as antibody development, vaccine production, and biosensor design further enhance market opportunities.

Key Questions Answered in the Report:

  • What are the primary factors driving the global growth of the in vitro protein expression market?
  • Which expression systems are gaining the highest adoption across different regions?
  • How are technological innovations influencing the competitive landscape of the in vitro protein expression market?
  • Who are the key players in the in vitro protein expression market, and what strategies are they employing to maintain their market positions?
  • What are the emerging trends and future outlooks for the global in vitro protein expression market?

Competitive Intelligence and Business Strategy:

Leading companies in the global in vitro protein expression market, such as Thermo Fisher Scientific Inc., Merck KGaA, and Promega Corporation, are focusing on product innovation and expanding their portfolios of expression systems. These companies are heavily investing in the development of advanced technologies for protein synthesis and establishing strategic partnerships with research institutes. Emphasis on sustainability and the introduction of eco-friendly reagents are emerging trends in the competitive landscape.

Key Companies Profiled:

  • Thermo Fisher Scientific, Inc.
  • Takara Bio Company
  • New England Biolabs
  • Promega Corporation
  • Jena Bioscience GmbH
  • GeneCopoeia, Inc.
  • Biotechrabbit GmbH
  • Cube Biotech GmbH
  • CellFree Sciences Co., Ltd.
  • Bioneer Corporation
  • Others.

In Vitro Protein Expression Industry Research by Category:

By Product Type

  • coli System
  • Rabbit Reticulocytes System
  • Wheat Germ System
  • Insect Cells System
  • Mammalian System

By Expression Mode

  • Continuous Flow Expression
  • Batch Expression

By End User

  • Biotechnological Companies
  • Pharmaceutical Companies
  • Contract Research Organizations
  • Academic and Research Institutes

By Application

  • Enzyme Engineering
  • Protein Labeling
  • Protein-Protein Interaction
  • Protein Purification

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • MEA

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Taxonomy
  • 2.2. Market Definition
  • 2.3. Product Comparison

3. Market View Point

  • 3.1. Macro-Economic Factors
  • 3.2. Drivers
    • 3.2.1. Supply Side Drivers
    • 3.2.2. Demand Side Drivers
  • 3.3. Restraints
  • 3.4. Opportunity Analysis
  • 3.5. Trends
  • 3.6. Pricing Analysis by Region
  • 3.7. Primary Insights and Verbatim

4. North America In-Vitro Protein Expression Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 4.1. Introduction
  • 4.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
    • 4.2.1. U.S.
    • 4.2.2. Canada
  • 4.3. Market Size (US$ Mn) Forecast By Country, 2024 - 2031
    • 4.3.1. U.S.
    • 4.3.2. Canada
  • 4.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
    • 4.4.1. E-coli In-Vitro Protein Expression System
    • 4.4.2. Rabbit Reticulocytes In-Vitro Protein Expression System
    • 4.4.3. Wheat Germ In-Vitro Protein Expression System
    • 4.4.4. Insect Cells In-Vitro Protein Expression System
    • 4.4.5. Mammalian In-Vitro Protein Expression System
  • 4.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
    • 4.5.1. E-coli In-Vitro Protein Expression System
    • 4.5.2. Rabbit Reticulocytes In-Vitro Protein Expression System
    • 4.5.3. Wheat Germ In-Vitro Protein Expression System
    • 4.5.4. Insect Cells In-Vitro Protein Expression System
    • 4.5.5. Mammalian In-Vitro Protein Expression System
  • 4.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
    • 4.6.1. Enzyme Engineering
    • 4.6.2. Protein Labeling
    • 4.6.3. Protein-Protein interaction
    • 4.6.4. Protein Purification
  • 4.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
    • 4.7.1. Enzyme Engineering
    • 4.7.2. Protein Labeling
    • 4.7.3. Protein-Protein interaction
    • 4.7.4. Protein Purification
  • 4.8. Historical Market Size (US$ Mn) Analysis By Expression System, 2019 - 2023
    • 4.8.1. Continuous Flow Expression System
    • 4.8.2. Batch Expression System
  • 4.9. Market Size (US$ Mn) Forecast By Expression System, 2024 - 2031
    • 4.9.1. Continuous Flow Expression System
    • 4.9.2. Batch Expression System
  • 4.10. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
    • 4.10.1. Biotechnological Companies
    • 4.10.2. Pharmaceutical Companies
    • 4.10.3. Contract Research Organizations
    • 4.10.4. Academic and Research Institutes
  • 4.11. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
    • 4.11.1. Biotechnological Companies
    • 4.11.2. Pharmaceutical Companies
    • 4.11.3. Contract Research Organizations
    • 4.11.4. Academic and Research Institutes
  • 4.12. Market Attractiveness Analysis
    • 4.12.1. By Country
    • 4.12.2. By Product Type
    • 4.12.3. By Application
    • 4.12.4. By Expression System
    • 4.12.5. By End User
  • 4.13. Drivers and Restraints: Impact Analysis
  • 4.14. Key Participants Market Presence (Intensity Map)

5. Latin America In-Vitro Protein Expression Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 5.1. Introduction
  • 5.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
    • 5.2.1. Brazil
    • 5.2.2. Mexico
    • 5.2.3. Argentina
    • 5.2.4. Rest of Latin America
  • 5.3. Market Size (US$ Mn) Forecast By Country, 2024 - 2031
    • 5.3.1. Brazil
    • 5.3.2. Mexico
    • 5.3.3. Argentina
    • 5.3.4. Rest of Latin America
  • 5.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
    • 5.4.1. E-coli In-Vitro Protein Expression System
    • 5.4.2. Rabbit Reticulocytes In-Vitro Protein Expression System
    • 5.4.3. Wheat Germ In-Vitro Protein Expression System
    • 5.4.4. Insect Cells In-Vitro Protein Expression System
    • 5.4.5. Mammalian In-Vitro Protein Expression System
  • 5.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
    • 5.5.1. E-coli In-Vitro Protein Expression System
    • 5.5.2. Rabbit Reticulocytes In-Vitro Protein Expression System
    • 5.5.3. Wheat Germ In-Vitro Protein Expression System
    • 5.5.4. Insect Cells In-Vitro Protein Expression System
    • 5.5.5. Mammalian In-Vitro Protein Expression System
  • 5.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
    • 5.6.1. Enzyme Engineering
    • 5.6.2. Protein Labeling
    • 5.6.3. Protein-Protein interaction
    • 5.6.4. Protein Purification
  • 5.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
    • 5.7.1. Enzyme Engineering
    • 5.7.2. Protein Labeling
    • 5.7.3. Protein-Protein interaction
    • 5.7.4. Protein Purification
  • 5.8. Historical Market Size (US$ Mn) Analysis By Expression System, 2019 - 2023
    • 5.8.1. Continuous Flow Expression System
    • 5.8.2. Batch Expression System
  • 5.9. Market Size (US$ Mn) Forecast By Expression System, 2024 - 2031
    • 5.9.1. Continuous Flow Expression System
    • 5.9.2. Batch Expression System
  • 5.10. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
    • 5.10.1. Biotechnological Companies
    • 5.10.2. Pharmaceutical Companies
    • 5.10.3. Contract Research Organizations
    • 5.10.4. Academic and Research Institutes
  • 5.11. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
    • 5.11.1. Biotechnological Companies
    • 5.11.2. Pharmaceutical Companies
    • 5.11.3. Contract Research Organizations
    • 5.11.4. Academic and Research Institutes
  • 5.12. Market Attractiveness Analysis
    • 5.12.1. By Country
    • 5.12.2. By Product Type
    • 5.12.3. By Application
    • 5.12.4. By Expression System
    • 5.12.5. By End User
  • 5.13. Drivers and Restraints: Impact Analysis
  • 5.14. Key Participants Market Presence (Intensity Map)

6. Europe In-Vitro Protein Expression Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 6.1. Introduction
  • 6.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
    • 6.2.1. U.K
    • 6.2.2. Germany
    • 6.2.3. France
    • 6.2.4. Spain
    • 6.2.5. Italy
    • 6.2.6. Poland
    • 6.2.7. Russia
    • 6.2.8. Rest of Europe
  • 6.3. Market Size (US$ Mn) Forecast By Country, 2024 - 2031
    • 6.3.1. U.K
    • 6.3.2. Germany
    • 6.3.3. France
    • 6.3.4. Spain
    • 6.3.5. Italy
    • 6.3.6. Poland
    • 6.3.7. Russia
    • 6.3.8. Rest of Europe
  • 6.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
    • 6.4.1. E-coli In-Vitro Protein Expression System
    • 6.4.2. Rabbit Reticulocytes In-Vitro Protein Expression System
    • 6.4.3. Wheat Germ In-Vitro Protein Expression System
    • 6.4.4. Insect Cells In-Vitro Protein Expression System
    • 6.4.5. Mammalian In-Vitro Protein Expression System
  • 6.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
    • 6.5.1. E-coli In-Vitro Protein Expression System
    • 6.5.2. Rabbit Reticulocytes In-Vitro Protein Expression System
    • 6.5.3. Wheat Germ In-Vitro Protein Expression System
    • 6.5.4. Insect Cells In-Vitro Protein Expression System
    • 6.5.5. Mammalian In-Vitro Protein Expression System
  • 6.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
    • 6.6.1. Enzyme Engineering
    • 6.6.2. Protein Labeling
    • 6.6.3. Protein-Protein interaction
    • 6.6.4. Protein Purification
  • 6.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
    • 6.7.1. Enzyme Engineering
    • 6.7.2. Protein Labeling
    • 6.7.3. Protein-Protein interaction
    • 6.7.4. Protein Purification
  • 6.8. Historical Market Size (US$ Mn) Analysis By Expression System, 2019 - 2023
    • 6.8.1. Continuous Flow Expression System
    • 6.8.2. Batch Expression System
  • 6.9. Market Size (US$ Mn) Forecast By Expression System, 2024 - 2031
    • 6.9.1. Continuous Flow Expression System
    • 6.9.2. Batch Expression System
  • 6.10. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
    • 6.10.1. Biotechnological Companies
    • 6.10.2. Pharmaceutical Companies
    • 6.10.3. Contract Research Organizations
    • 6.10.4. Academic and Research Institutes
  • 6.11. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
    • 6.11.1. Biotechnological Companies
    • 6.11.2. Pharmaceutical Companies
    • 6.11.3. Contract Research Organizations
    • 6.11.4. Academic and Research Institutes
  • 6.12. Market Attractiveness Analysis
    • 6.12.1. By Country
    • 6.12.2. By Product Type
    • 6.12.3. By Application
    • 6.12.4. By Expression System
    • 6.12.5. By End User
  • 6.13. Drivers and Restraints: Impact Analysis
  • 6.14. Key Participants Market Presence (Intensity Map)

7. Asia Pacific In-Vitro Protein Expression Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 7.1. Introduction
  • 7.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
    • 7.2.1. China
    • 7.2.2. Japan
    • 7.2.3. Australia
    • 7.2.4. India
    • 7.2.5. Rest of Asia-Pacific
  • 7.3. Market Size (US$ Mn) Forecast By Country, 2024 - 2031
    • 7.3.1. China
    • 7.3.2. Japan
    • 7.3.3. Australia
    • 7.3.4. India
    • 7.3.5. Rest of Asia Pacific
  • 7.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
    • 7.4.1. E-coli In-Vitro Protein Expression System
    • 7.4.2. Rabbit Reticulocytes In-Vitro Protein Expression System
    • 7.4.3. Wheat Germ In-Vitro Protein Expression System
    • 7.4.4. Insect Cells In-Vitro Protein Expression System
    • 7.4.5. Mammalian In-Vitro Protein Expression System
  • 7.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
    • 7.5.1. E-coli In-Vitro Protein Expression System
    • 7.5.2. Rabbit Reticulocytes In-Vitro Protein Expression System
    • 7.5.3. Wheat Germ In-Vitro Protein Expression System
    • 7.5.4. Insect Cells In-Vitro Protein Expression System
    • 7.5.5. Mammalian In-Vitro Protein Expression System
  • 7.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
    • 7.6.1. Enzyme Engineering
    • 7.6.2. Protein Labeling
    • 7.6.3. Protein-Protein interaction
    • 7.6.4. Protein Purification
  • 7.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
    • 7.7.1. Enzyme Engineering
    • 7.7.2. Protein Labeling
    • 7.7.3. Protein-Protein interaction
    • 7.7.4. Protein Purification
  • 7.8. Historical Market Size (US$ Mn) Analysis By Expression System, 2019 - 2023
    • 7.8.1. Continuous Flow Expression System
    • 7.8.2. Batch Expression System
  • 7.9. Market Size (US$ Mn) Forecast By Expression System, 2024 - 2031
    • 7.9.1. Continuous Flow Expression System
    • 7.9.2. Batch Expression System
  • 7.10. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
    • 7.10.1. Biotechnological Companies
    • 7.10.2. Pharmaceutical Companies
    • 7.10.3. Contract Research Organizations
    • 7.10.4. Academic and Research Institutes
  • 7.11. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
    • 7.11.1. Biotechnological Companies
    • 7.11.2. Pharmaceutical Companies
    • 7.11.3. Contract Research Organizations
    • 7.11.4. Academic and Research Institutes
  • 7.12. Market Attractiveness Analysis
    • 7.12.1. By Country
    • 7.12.2. By Product Type
    • 7.12.3. By Application
    • 7.12.4. By Expression System
    • 7.12.5. By End User
  • 7.13. Drivers and Restraints: Impact Analysis
  • 7.14. Key Participants Market Presence (Intensity Map)

8. MEA In-Vitro Protein Expression Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 8.1. Introduction
  • 8.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
    • 8.2.1. GCC Countries
    • 8.2.2. South Africa
    • 8.2.3. Rest of MEA
  • 8.3. Market Size (US$ Mn) Forecast By Country, , 2024 - 2031
    • 8.3.1. GCC Countries
    • 8.3.2. South Africa
    • 8.3.3. Rest of MEA
  • 8.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
    • 8.4.1. E-coli In-Vitro Protein Expression System
    • 8.4.2. Rabbit Reticulocytes In-Vitro Protein Expression System
    • 8.4.3. Wheat Germ In-Vitro Protein Expression System
    • 8.4.4. Insect Cells In-Vitro Protein Expression System
    • 8.4.5. Mammalian In-Vitro Protein Expression System
  • 8.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
    • 8.5.1. E-coli In-Vitro Protein Expression System
    • 8.5.2. Rabbit Reticulocytes In-Vitro Protein Expression System
    • 8.5.3. Wheat Germ In-Vitro Protein Expression System
    • 8.5.4. Insect Cells In-Vitro Protein Expression System
    • 8.5.5. Mammalian In-Vitro Protein Expression System
  • 8.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
    • 8.6.1. Enzyme Engineering
    • 8.6.2. Protein Labeling
    • 8.6.3. Protein-Protein interaction
    • 8.6.4. Protein Purification
    • 8.6.5. Targeted Sequencing
  • 8.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
    • 8.7.1. Enzyme Engineering
    • 8.7.2. Protein Labeling
    • 8.7.3. Protein-Protein interaction
    • 8.7.4. Protein Purification
  • 8.8. Historical Market Size (US$ Mn) Analysis By Expression System, 2019 - 2023
    • 8.8.1. Continuous Flow Expression System
    • 8.8.2. Batch Expression System
  • 8.9. Market Size (US$ Mn) Forecast By Expression System, 2024 - 2031
    • 8.9.1. Continuous Flow Expression System
    • 8.9.2. Batch Expression System
  • 8.10. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
    • 8.10.1. Biotechnological Companies
    • 8.10.2. Pharmaceutical Companies
    • 8.10.3. Contract Research Organizations
    • 8.10.4. Academic and Research Institutes
  • 8.11. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
    • 8.11.1. Biotechnological Companies
    • 8.11.2. Pharmaceutical Companies
    • 8.11.3. Contract Research Organizations
    • 8.11.4. Academic and Research Institutes
  • 8.12. Market Attractiveness Analysis
    • 8.12.1. By Country
    • 8.12.2. By Product Type
    • 8.12.3. By Application
    • 8.12.4. By Expression System
    • 8.12.5. By End User
  • 8.13. Drivers and Restraints: Impact Analysis
  • 8.14. Key Participants Market Presence (Intensity Map)

9. Forecast Factors: Relevance and Impact

10. Competition Landscape

  • 10.1. Market Structure
  • 10.2. Company Share Analysis (2024)
  • 10.3. Competition Dashboard
  • 10.4. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments and SWOT Analysis)
    • 10.4.1. Thermo Fisher Scientific, Inc.
    • 10.4.2. Takara Bio Company
    • 10.4.3. New England Biolabs
    • 10.4.4. Promega Corporation
    • 10.4.5. Jena Bioscience GmbH
    • 10.4.6. GeneCopoeia, Inc.
    • 10.4.7. Biotechrabbit GmbH
    • 10.4.8. Cube Biotech GmbH
    • 10.4.9. CellFree Sciences Co., Ltd.
    • 10.4.10. Bioneer Corporation

11. Global In-Vitro Protein Expression Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Region

  • 11.1. Historical Market Size (US$ Mn) Analysis By Region, 2019 - 2023
    • 11.1.1. North America
    • 11.1.2. Latin America
    • 11.1.3. Europe
    • 11.1.4. Asia Pacific
    • 11.1.5. Middle East and Africa
  • 11.2. Market Size (US$ Mn) Forecast By Region, 2024 - 2031
    • 11.2.1. North America
    • 11.2.2. Latin America
    • 11.2.3. Europe
    • 11.2.4. Asia Pacific
    • 11.2.5. Middle East and Africa
  • 11.3. Market Attractiveness Analysis By Region

12. Global In-Vitro Protein Expression Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Product Type

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
    • 12.2.1. E-coli In-Vitro Protein Expression System
    • 12.2.2. Rabbit Reticulocytes In-Vitro Protein Expression System
    • 12.2.3. Wheat Germ In-Vitro Protein Expression System
    • 12.2.4. Insect Cells In-Vitro Protein Expression System
    • 12.2.5. Mammalian In-Vitro Protein Expression System
  • 12.3. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
    • 12.3.1. E-coli In-Vitro Protein Expression System
    • 12.3.2. Rabbit Reticulocytes In-Vitro Protein Expression System
    • 12.3.3. Wheat Germ In-Vitro Protein Expression System
    • 12.3.4. Insect Cells In-Vitro Protein Expression System
    • 12.3.5. Mammalian In-Vitro Protein Expression System
  • 12.4. Market Attractiveness Analysis By Product Type

13. Global In-Vitro Protein Expression Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Application

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
    • 13.2.1. Enzyme Engineering
    • 13.2.2. Protein Labeling
    • 13.2.3. Protein-Protein interaction
    • 13.2.4. Protein Purification
  • 13.3. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
    • 13.3.1. Enzyme Engineering
    • 13.3.2. Protein Labeling
    • 13.3.3. Protein-Protein interaction
    • 13.3.4. Protein Purification
  • 13.4. Market Attractiveness Analysis By Application

14. Global In-Vitro Protein Expression Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Expression System

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Analysis By Expression System, 2019 - 2023
    • 14.2.1. Continuous Flow Expression System
    • 14.2.2. Batch Expression System
  • 14.3. Market Size (US$ Mn) Forecast By Expression System, 2024 - 2031
    • 14.3.1. Continuous Flow Expression System
    • 14.3.2. Batch Expression System
  • 14.4. Market Attractiveness Analysis By Expression System

15. Global In-Vitro Protein Expression Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By End User

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
    • 15.2.1. Biotechnological Companies
    • 15.2.2. Pharmaceutical Companies
    • 15.2.3. Contract Research Organizations
    • 15.2.4. Academic and Research Institutes
  • 15.3. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
    • 15.3.1. Biotechnological Companies
    • 15.3.2. Pharmaceutical Companies
    • 15.3.3. Contract Research Organizations
    • 15.3.4. Academic and Research Institutes
  • 15.4. Market Attractiveness Analysis By End User

16. Global Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 16.1. Market Size Analysis and Y-o-Y Growth
  • 16.2. Absolute $ Opportunity
  • 16.3. Market Volume and Y-o-Y Growth
  • 16.4. Value Chain

17. Research Methodology